Pre-transplant Thymic Function Predicts Is Associated With Patient Death After Kidney Transplantation

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2020 Sep 9

PMID 32903778

Citations 8

Authors

Cecile Courivaud

Jamal Bamoulid

Thomas Crepin

Emilie Gaiffe

Caroline Laheurte

Philippe Saas

Didier Ducloux

Affiliations

Soon will be listed here.

Abstract

Accelerated thymic involution is a main feature of end-stage renal disease (ESRD)-associated immune senescence. Recent evidences suggest that ESRD-associated immune senescence is associated with adverse outcomes in dialysis patients. However, no study focused on the association between pre-transplant thymic function and patient survival after transplantation. We conducted a prospective, multicenter study to assess whether pre-transplant thymic function measured by recent thymic emigrants (RTE) may predict death after first kidney transplantation. Results were tested in a validation cohort. Nine hundred and sixty-seven incident kidney transplant recipients were included in the prospective study. Mean follow up was 5.1 + 2.9 years. Eighty two patients (8.5%) died during follow up. Lower RTE levels were associated with a higher risk of death (2.53; 95%CI, 1.54-4.39 for each decrease of 1 log in RTE; < 0.001). Cancer-related death was particularly increased in patients with low RTE levels (4.23; 95%CI, 1.43-12.13; = 0.007). One hundred and thirty-six patients having received a first kidney transplantation were included in the validation cohort. Lower TREC levels were associated with higher risk of death (1.90; 95%CI, 1.11-3.51 for each decrease of 1 log in RTE; = 0.025). RTE were not associated with death-censored graft loss. Pre-transplant thymic function is strongly associated with death after transplantation. Attempt to reverse ESRD-related thymic loss may prevent premature death.

Citing Articles

Exhaustion of CD8 central memory regulatory T cell differentiation is involved in renal allograft rejection.

Kalble F, Leonhard J, Zeier M, Zivanovic O, Schaier M, Steinborn A Front Immunol. 2025; 16:1532086.

PMID: 39925813 PMC: 11802571. DOI: 10.3389/fimmu.2025.1532086.

T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease.

Granda Alacote A, Goyoneche Linares G, Castaneda Torrico M, Diaz-Obregon D, Nunez M, Murillo Carrasco A Biomedicines. 2025; 13(1).

PMID: 39857588 PMC: 11759818. DOI: 10.3390/biomedicines13010003.

Immune aging: biological mechanisms, clinical symptoms, and management in lung transplant recipients.

Kapse B, Budev M, Singer J, Greenland J Front Transplant. 2024; 3:1356948.

PMID: 38993782 PMC: 11235310. DOI: 10.3389/frtra.2024.1356948.

Anti-staphylococcus aureus adaptive immunity is impaired in end-stage renal disease patients on hemodialysis: one-year longitudinal study.

Darbouret-Hervier A, Assi N, Asensio M, Bernabe B, Lechevallier A, Iantomasi R Front Immunol. 2023; 14:1123160.

PMID: 37304264 PMC: 10250961. DOI: 10.3389/fimmu.2023.1123160.

Exhaustion of CD8 central memory responder T cell differentiation provokes non-melanoma skin cancer in elderly kidney transplant recipients.

Leonhard J, Schaier M, Kalble F, Zeier M, Steinborn A Front Immunol. 2023; 14:1164284.

PMID: 37287988 PMC: 10242110. DOI: 10.3389/fimmu.2023.1164284.

References

Dedeoglu B, Meijers R, Klepper M, Hesselink D, Baan C, Litjens N . Uremia-Associated Premature Aging of T Cells Does Not Predict Infectious Complications After Renal Transplantation. Am J Transplant. 2016; 16(8):2324-33. DOI: 10.1111/ajt.13759. View

Crepin T, Carron C, Roubiou C, Gaugler B, Gaiffe E, Simula-Faivre D . ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients. Am J Transplant. 2015; 15(4):1028-38. DOI: 10.1111/ajt.13092. View

Ducloux D, Carron P, Motte G, Ab A, Rebibou J, Bresson-Vautrin C . Lymphocyte subsets and assessment of cancer risk in renal transplant recipients. Transpl Int. 2002; 15(8):393-6. DOI: 10.1007/s00147-002-0410-4. View

Bamoulid J, Courivaud C, Crepin T, Carron C, Gaiffe E, Roubiou C . Pretransplant thymic function predicts acute rejection in antithymocyte globulin-treated renal transplant recipients. Kidney Int. 2016; 89(5):1136-1143. DOI: 10.1016/j.kint.2015.12.044. View

Mackall C, Fry T, Gress R . Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 2011; 11(5):330-42. PMC: 7351348. DOI: 10.1038/nri2970. View

Crepin T, Gaiffe E, Courivaud C, Roubiou C, Laheurte C, Moulin B . Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections. Transpl Infect Dis. 2016; 18(3):415-22. DOI: 10.1111/tid.12534. View

Hope C, Grace B, Pilkington K, Coates P, Bergmann I, Carroll R . The immune phenotype may relate to cancer development in kidney transplant recipients. Kidney Int. 2014; 86(1):175-83. DOI: 10.1038/ki.2013.538. View

Francois B, Jeannet R, Daix T, Walton A, Shotwell M, Unsinger J . Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018; 3(5). PMC: 5922293. DOI: 10.1172/jci.insight.98960. View

Crepin T, Legendre M, Carron C, Vachey C, Courivaud C, Rebibou J . Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients. Nephrol Dial Transplant. 2018; 35(4):624-632. DOI: 10.1093/ndt/gfy276. View

10.

Sheikh V, Porter B, DerSimonian R, Kovacs S, Thompson W, Perez-Diez A . Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia. Blood. 2015; 127(8):977-88. PMC: 4768432. DOI: 10.1182/blood-2015-05-645077. View

11.

Alpdogan O, van den Brink M . IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol. 2005; 26(1):56-64. DOI: 10.1016/j.it.2004.11.002. View

12.

Ferrando-Martinez S, Romero-Sanchez M, Solana R, Delgado J, de la Rosa R, Munoz-Fernandez M . Thymic function failure and C-reactive protein levels are independent predictors of all-cause mortality in healthy elderly humans. Age (Dordr). 2011; 35(1):251-9. PMC: 3543745. DOI: 10.1007/s11357-011-9341-2. View

13.

Ducloux D, Bamoulid J, Courivaud C, Gaugler B, Rebibou J, Ferrand C . Thymic function, anti-thymocytes globulins, and cancer after renal transplantation. Transpl Immunol. 2011; 25(1):56-60. DOI: 10.1016/j.trim.2011.05.003. View

14.

Falci C, Gianesin K, Sergi G, Giunco S, De Ronch I, Valpione S . Immune senescence and cancer in elderly patients: results from an exploratory study. Exp Gerontol. 2013; 48(12):1436-42. DOI: 10.1016/j.exger.2013.09.011. View

15.

Van Lent A, Dontje W, Nagasawa M, Siamari R, Bakker A, Pouw S . IL-7 enhances thymic human T cell development in "human immune system" Rag2-/-IL-2Rgammac-/- mice without affecting peripheral T cell homeostasis. J Immunol. 2009; 183(12):7645-55. DOI: 10.4049/jimmunol.0902019. View

16.

Thibaudin D, Alamartine E, Mariat C, Absi L, Berthoux F . Long-term kinetic of T-lymphocyte subsets in kidney-transplant recipients: influence of anti-T-cell antibodies and association with posttransplant malignancies. Transplantation. 2005; 80(10):1514-7. DOI: 10.1097/01.tp.0000181193.98026.3f. View

17.

Betjes M, Langerak A, van der Spek A, de Wit E, Litjens N . Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int. 2011; 80(2):208-17. DOI: 10.1038/ki.2011.110. View

18.

Betjes M, Meijers R, de Wit E, Weimar W, Litjens N . Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection. Transplantation. 2012; 94(1):63-9. DOI: 10.1097/TP.0b013e31825306ff. View

19.

Woodland D, Kotzin B, Palmer E . Functional consequences of a T cell receptor D beta 2 and J beta 2 gene segment deletion. J Immunol. 1990; 144(1):379-85. View

20.

Kohler S, Thiel A . Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood. 2008; 113(4):769-74. DOI: 10.1182/blood-2008-02-139154. View